One-liner: Eko develops digital stethoscopes and AI tools for early detection of cardiac and pulmonary diseases in the healthcare sector.
Company slogan: Eko Health is a leader in AI technology for heart and lung disease detection. Early Detection is Primary.
Positioning: “Eko positions itself as a provider of advanced digital stethoscope technology and AI disease detection tools, focusing on enhancing the capabilities of healthcare professionals.”
Description: “Eko Health, Inc. (Eko) is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes and AI detection platform, SENSORA™. The company’s FDA-cleared technologies are used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others.”
Employees: 196
Website: Visit websiteHeadquarters: “Emeryville, California”
Ownership: Privately Held
Founded: 2013
Company type: AI company
Use cases: “cardiac disease detection, pulmonary disease detection, telehealth”
Pricing: “$429, $409, $379, $329, $259”
Client sector: healthcare
Business model: subscription
Products: “CORE 500™, Eko App, SENSORA™”
Is API available: no
Website title: Echo Labs | Captioning for Higher Education
Website description: none
Linkedin: https://www.linkedin.com/company/eko-health
Youtube: https://www.youtube.com/channel/UCPWaDhc8yTKhXhrNBYLCX2A
Instagram: https://www.instagram.com/ekohealth/
Facebook: https://www.facebook.com/eko
Twitter: https://twitter.com/Eko_Health
Crunchbase: https://www.crunchbase.com/organization/eko-health
Email: teamorders@ekohealth.com